Helping people quit smokeless tobacco using text messages
A Text-Based Scheduled Reduction Intervention for Smokeless Tobacco Cessation
This study is testing a new way to help people in rural areas quit smokeless tobacco by sending them personalized text messages that gradually reduce their tobacco use, and it aims to see if this method works better than regular text support.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Duke University NIH-funded |
| Lab location | 1 site (Durham, United States) |
| Project ID | NIH-10703375 on NIH RePORTER |
What this research studies
This research investigates a new approach to help individuals quit using smokeless tobacco, particularly in rural and underserved populations. It employs a method called Scheduled Gradual Reduction (SGR), which involves gradually decreasing tobacco use through a personalized schedule delivered via text messages. This innovative intervention aims to address common challenges faced by users, such as strong cravings and withdrawal symptoms, by providing ongoing support and guidance. The study will compare the effectiveness of the SGR intervention with a control group receiving standard text-based support.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals who use smokeless tobacco and are motivated to quit, particularly those from rural or underserved communities.
Not a fit: Patients who do not use smokeless tobacco or those who are not interested in quitting may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could significantly improve cessation rates among smokeless tobacco users, leading to better health outcomes and reduced rates of tobacco-related cancers.
How similar studies have performed: Previous research has shown promise in using text-based interventions for smoking cessation, suggesting that this approach may be effective for smokeless tobacco users as well.
Where this research is happening
Durham, United States
- Duke University — Durham, United States (Active)
Researchers
- Principal investigator: Noonan, Devon — Duke University
- Study coordinator: Noonan, Devon
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.